Leqembi sales improved sequentially in the past two quarters, with the positive trend expected to continue in the first quarter. Leqembi sales are recorded by Eisai. Leqembi has already been launched in the United States, Japan, China and some other countries. On the fourth-quarter conference call, the company had said it is seeing strong growth in China and Japan, which is likely to have contributed to growth in the first quarter of 2025. Leqembi was approved in the European Union earlier this month.